174 related articles for article (PubMed ID: 29023696)
1. Tumor-infiltrating tryptase
Hu G; Wang S; Cheng P
Int J Cancer; 2018 Feb; 142(4):813-821. PubMed ID: 29023696
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of tumor-infiltrating CD57-positive lymphocytes in solid tumors: a meta-analysis.
Hu G; Wang S
Oncotarget; 2018 Jan; 9(8):8111-8119. PubMed ID: 29487719
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors.
Hu G; Wang S; Xu F; Ding Q; Chen W; Zhong K; Huang L; Xu Q
Cell Physiol Biochem; 2018; 51(3):1041-1050. PubMed ID: 30476924
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating CD45RO
Hu G; Wang S
Sci Rep; 2017 Sep; 7(1):10376. PubMed ID: 28871164
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis.
Wang S; Li Z; Hu G
Oncotarget; 2017 Sep; 8(39):66382-66391. PubMed ID: 29029520
[TBL] [Abstract][Full Text] [Related]
6. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
[TBL] [Abstract][Full Text] [Related]
7. High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases.
Suzuki S; Ichikawa Y; Nakagawa K; Kumamoto T; Mori R; Matsuyama R; Takeda K; Ota M; Tanaka K; Tamura T; Endo I
BMC Cancer; 2015 Nov; 15():840. PubMed ID: 26530140
[TBL] [Abstract][Full Text] [Related]
8. Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor.
Alì G; Boldrini L; Lucchi M; Mussi A; Corsi V; Fontanini G
J Thorac Oncol; 2009 Mar; 4(3):348-54. PubMed ID: 19155997
[TBL] [Abstract][Full Text] [Related]
9. Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery.
Ammendola M; Sacco R; Zuccalà V; Luposella M; Patruno R; Gadaleta P; Zizzo N; Gadaleta CD; De Sarro G; Sammarco G; Oltean M; Ranieri G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854307
[TBL] [Abstract][Full Text] [Related]
10. Tryptase expression as a prognostic marker in patients with resected gastric cancer.
Lin C; Liu H; Zhang H; Cao Y; Li R; Wu S; Li H; He H; Xu J; Sun Y
Br J Surg; 2017 Jul; 104(8):1037-1044. PubMed ID: 28542986
[TBL] [Abstract][Full Text] [Related]
11. The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis.
de Souza Junior DA; Santana AC; da Silva EZ; Oliver C; Jamur MC
Biomed Res Int; 2015; 2015():142359. PubMed ID: 26146612
[TBL] [Abstract][Full Text] [Related]
12. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating FoxP3
Hu G; Li Z; Wang S
Oncotarget; 2017 Sep; 8(43):75361-75371. PubMed ID: 29088871
[TBL] [Abstract][Full Text] [Related]
16. Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients.
Hu G; Xu F; Zhong K; Wang S; Huang L; Chen W
J Cancer; 2018; 9(20):3736-3742. PubMed ID: 30405845
[No Abstract] [Full Text] [Related]
17. High density of tryptase-positive mast cells in patients with renal cell carcinoma on hemodialysis: correlation with expression of stem cell factor and protease activated receptor-2.
Watanabe S; Miyata Y; Matsuo T; Mochizuki Y; Nishikido M; Hayashi T; Sakai H
Hum Pathol; 2012 Jun; 43(6):888-97. PubMed ID: 22204707
[TBL] [Abstract][Full Text] [Related]
18. Mast cells and cancer.
Paolino G; Corsetti P; Moliterni E; Corsetti S; Didona D; Albanesi M; Mattozzi C; Lido P; Calvieri S
G Ital Dermatol Venereol; 2019 Dec; 154(6):650-668. PubMed ID: 29192477
[TBL] [Abstract][Full Text] [Related]
19. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
20. Tryptase as a polyfunctional component of mast cells.
Atiakshin D; Buchwalow I; Samoilova V; Tiemann M
Histochem Cell Biol; 2018 May; 149(5):461-477. PubMed ID: 29532158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
